No Data
PHARMARON (03759) received a total of approximately 40.9212 million shares pledged by its actual controller and its concerted parties, and 53.52 million shares of the company were unpledged.
PHARMARON (03759) announced that it recently received notice from the company's actual controller, Mr. Lou Xiaoqiang, Ms. Zheng Bei, and their concerted actions...
PHARMARON (03759) spent HKD 40.3088 million to buy back 2.9518 million shares on December 27.
PHARMARON (03759) announced that on December 27, 2024, it will spend 40.3088 million Hong Kong dollars to buy back...
In the shareholder letter of PHARMARON (300759.SZ), it is proposed that Kangcheng intends to reduce its Shareholding by no more than 10.6667 million shares.
PHARMARON (300759.SZ) announced that the company recently received a notice from a shareholder holding over 5% of shares, Shenzhen Xinchungang Cheng...
PHARMARON (03759.HK) canceled 9.6083 million repurchased shares on December 25.
Gelonghui reported on December 26 that PHARMARON (03759.HK) announced that on December 25, 2024, the company will cancel 9.6083 million repurchased shares.
On December 24, PHARMARON (03759.HK) spent 0.6746 million Hong Kong dollars to repurchase 0.0482 million shares.
On December 24, Gelonghui reported that PHARMARON (03759.HK) announced the expenditure of 0.6746 million HKD to repurchase 0.0482 million shares on December 24, 2024, with a repurchase price of 13.98-14 HKD per share.
On December 23, PHARMARON (03759.HK) spent 13.9286 million HKD to repurchase 1 million shares.
Gelonghui reported on December 23 that PHARMARON (03759.HK) announced a repurchase of 1 million shares at a cost of HKD 13.9286 million on December 23, 2024, with a repurchase price per share of HKD 13.76-14.
Expand
102884128 : getting disappointed with this counter. every day drop.